Leukosialin (CD43) is proteolytically cleaved from stimulated HMC-1 cells

Immunobiology

Volumn 197, Issue 1, 1997, Pages 82-96

  Weber, Sylvia ^a   Babina, Magda ^b   Hermann, Bettina ^b   Henz, Beate M ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLOROISOCOUMARIN; BENZAMIDINE; BENZYLSULFONYL FLUORIDE; CHYMOTRYPSIN A; ELASTASE; LEUKOSIALIN; PAPAIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEINASE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SIALIDASE; SIALOPROTEIN; SUBTILISIN; TRYPSIN;

ARTHROBACTER; ARTICLE; CELL ACTIVATION; CELL LINE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LEUKOCYTE; MAST CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEIN TRANSPORT; PROTEINASE INHIBITION; VIBRIO CHOLERAE;

EID: 0030873444     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80059-9     Document Type: Article

References (30)

1. MENTZER, S. J., E. REMOLD-O'DONNEL, M. A. V. CRIMMINS, E. BIERER, F. S. ROSEN, and S. J. BURAKOFF. 1987. Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation. J. Exp. Med. 165: 1383.
2. AXELSSON, B., R. YOUSEFFI-ETEMAD, S. HAMMARSTRÖM, and P. PERLMANN. 1988. Induction of aggregation and enhancement of proliferation and IL-2 secretion in human T cells by antibodies to CD43. J. Immunol. 142: 2912.
3. NONG, Y. H., E. REMOLD-O'DONNEL, T. W. LE BIEN, and H. G. REMOLD. 1989. A monoclonal antibody to sialophorin (CD43) induces homotypic adhesion and activation of human monocytes. J. Exp. Med. 170: 259.
4. SILVERMAN, L., R. C. K. WONG, E. REMOLD-O'DONNELL, D. VERCELLI, J. SANCHO, C. TERHORST, F. ROSEN, R. GEHA, and T. CHATILA. 1989. Mechanism of mononuclear cell activation by an anti-CD43 (sialophorin) agonist antibody. J. Immunol. 142: 4194.
5. WONG, R. C. K., E. REMOLD-O'DONNELL, D. VERCELLI, J. SANCHO, C. TERHORST, F. ROSEN, R. GEHA, and T. CHATILA. 1990. Signal transduction via leukocyte antigen CD43 (sialophorin). Feedback regulation by protein kinase C. J. Immunol. 144: 1455.
6. ROSENSTEIN, Y., J. K. PARK, W. C. HAHN, F. S. ROSEN, and B. E. BIERER. 1991. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature 354: 233.
7. ARDMAN, B., M. A. SIKORSKI, and D. E. STAUNTON. 1992. CD43 interferes with T-lymphocyte adhesion. Proc. Natl. Acad. Sci U.S.A. 89: 5001.
8. CYSTER, J. G., and A. F. WILLIAMS. 1992. The importance of cross-linking in the homotypic aggregation of lymphocytes induced by anti-leukosialin (CD43) antibodies. Eur. J. Immunol. 22: 2565.
9. KUIJPERS, T. W., M. HOOGERWERF, K. C. KUIJPERS, B. R. SCHWARTZ, and J. M. HARLAN. 1992. Cross-linking of sialophorin (CD43) induces neutrophil aggregation in a CD18-dependent and CD18-independent way. J. Immunol. 149: 998.
10. CHATILA, T., and R. S. GEHA. 1988. Phosphorylation of T cell membrane proteins by activators of protein kinase C. J. Immunol. 140: 4308.
11. PILLER, F., V. PILLER, R. I. FOX, and M. FUKUDA. 1988. Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J. Biol. Chem. 263: 15146.
12. AXELSSON, B., and P. PERLMANN. 1989. Persistent superphosphorylation of leukosialin (CD43) in activated T cells and in tumour cell lines. Scand. J. Immunol. 30: 539.
13. FUKUDA, M. 1989. Leukosialin, a major sialoglycoprotein defining leukocyte differentiation. Ciba Found Symp. 145: 257.
14. PILLER, V., F. PILLER, and M. FUKUDA. Phosphorylation of the major leukocyte surface sialoglycoprotein, leukosialin, is increased by phorbol 12-myristate 13-acetate. J. Biol. Chem. 264: 18824.
15. CAMPANERO, M. R., R. PULIDO, J. L. ALONSO, J. P. PIVEL, F. X. PIMENTEL-MUIÑOS, M. FRESNO, and F. SÁNCHEZ-MADRID. 1991. Down-regulation by tumor necrosis factor-α of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism. Eur. J. Immunol. 21: 3045.
16. RIEU, P., F. PORTEU, G. BESSOU, P. LESAVRE, and L. HALBWACHS-MECARELLI. 1992. Human neutrophils release their major membrane sialoprotein, leukosialin (CD43), during cell activation. Eur. J. Immunol. 22: 3021.
17. BAŽIL, V., and J. L. STROMINGER. 1993. CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes. Proc. Natl. Acad. Sci. U.S.A. 90: 3792.
18. BAŽIL, V., and J. L. STROMINGER. 1994. Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Induction of cleavage of L-selectin via CD16. J. Immunol. 152: 1314.
19. REMOLD-O'DONNEL, E., and D. PARENT. 1994. Two proteolytic pathways for down-regulation of the barrier molecule CD43 of human neutrophils. J. Immunol. 152: 3595.
20. SCHMID, K., M. A. HEDINGER, R. BROSSMER, J. H. COLLINS, T. HAUPT, G. D. MARTI, J. OFFNER, J. SCHALLER, K. TAKAGAKI, M. T. WALSH, H. G. SCHWICK, F. S. ROSEN, and E. REMOLD-O'DONNEL. 1992. Amino acid sequence of human plasma galactoglycoprotein: identity with the extracellular region of CD43 (sialophorin). Proc. Natl. Acad. Sci. U.S.A. 89: 663.
21. WEBER, S., B. RUH, E. DIPPEL, and B. M. CZARNETZKI. 1994. Monoclonal antibodies to leucosialin (CD43) induce homotypic aggregation of the human mast cell line HMC-1: characterization of leucosialin on HMC-1 cells. Immunology 82: 638.
22. BUTTERFIELD, J. H., D. WEILER, G. DEWALD, and G. J. GLEICH. 1988. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 12: 345.
23. WEBER, S., M. BABINA, S. KRÜGER-KRASAGAKES, A. GRÜTZKAU, and B. M. HENZ. 1996. A subclone (5C6) of the human mast cell line HMC-1 represents a more differentiated phenotype than the original cell line. Arch. Dermatol. Res. 288: 778.
24. LAEMMLI, U. K. 1970. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680.
25. REMOLD-O'DONNEL, E., and F. S. ROSEN. 1990. Proteolytic fragmentation of sialophorin (CD43). Localization of the activation-inducing site and examination of the role of sialic acid. J. Immunol. 145: 3372.
26. HAMANN, K., J. GRABBE, P. WELKER, N. HAAS, B. ALGERMISSEN, and B. M. CZARNETZKI. 1994. Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch. Dermatol. Res. 286: 380.
27. NILSSON, G., T. BLOM, M. KUSCHE-GULBERG, L. KJELEEN, J. H. BUTTERFIELD, C. SUNDSTROM, K. NILSSON, and L. HELLMANN. 1994. Phenotypic characterization of the human mast-cell line HMC-1. Scand. J. Immunol. 39: 489.
28. WEBER, S., S. KRÜGER-KRASAGAKES, J. GRABBE, T. ZUBERBIER, and B. M. CZARNETZKI: Mast cells. 1995. Int. J. Dermatol. 14: 1.
29. FRANDJI, P., C. OSKÉRITZIAN, F. CACARACI, J. LAPEYRE, R. PERONET, B. DAVID, J. G. GUILETT, and S. MÉCHERI. 1993. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151: 6318.
30. MALAVIYA, R., E. A. ROSS, J. I. MACGREGOR, T. IKEDA, J. R. LITTLE, B. A. JAKSCHIK, and S. N. ABRAHAM. 1994. Mast cell phagocytosis of FimH-expressing enterobacteria. J. Immunol. 152: 1907.